Budesonide impurity C structure
|
Common Name | Budesonide impurity C | ||
|---|---|---|---|---|
| CAS Number | 1040085-99-1 | Molecular Weight | 430.534 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 607.0±55.0 °C at 760 mmHg | |
| Molecular Formula | C25H34O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 204.6±25.0 °C | |
Use of Budesonide impurity CBudesonide impurity C is an impurity of Budesonide. Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist[1][2]. |
| Name | (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-5-Hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-4b,6,6a,7a,10a,11,11a,11b,12,13-decahydrochryseno[2,3-d][1,3]dioxole-2,7(4aH,5H)-dione |
|---|---|
| Synonym | More Synonyms |
| Description | Budesonide impurity C is an impurity of Budesonide. Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Budesonide is selective for human glucocorticoid receptor (hGR; EC50=45.7 pM) over mineralocorticoid receptors (EC50=7,620 pM) in CV-1 cells[1]. Budesonide (30 min prior to LPS) suppresses the activation of the NLRP3 inflammasome by LPS (100 ng/mL) plus ATP (5 mM) in macrophages (RAW 264.7 cells)[2]. |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 607.0±55.0 °C at 760 mmHg |
| Molecular Formula | C25H34O6 |
| Molecular Weight | 430.534 |
| Flash Point | 204.6±25.0 °C |
| Exact Mass | 430.235535 |
| LogP | 2.56 |
| Vapour Pressure | 0.0±3.9 mmHg at 25°C |
| Index of Refraction | 1.592 |
| (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-5-Hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-4b,6,6a,7a,10a,11,11a,11b,12,13-decahydrochryseno[2,3-d][1,3]dioxole-2,7(4aH,5H)-dione |
| Chryseno[2,3-d][1,3]dioxole-2,7(4aH,5H)-dione, 4b,6,6a,7a,10a,11,11a,11b,12,13-decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-, (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)- |
| Budesonide Impurity 3 |